Skip to main content
Premium Trial:

Request an Annual Quote

Wylie Chenn, Samuel Broder, and Shirley Tilghman

Serologicals has named Wylie Chenn as regional director for the Asia/Pacific region, the company said last week. Chenn was most recently general manager, bioscience division for the Asia/Pacific region for Fisher Scientific. He received a BS in marketing and international business from Brigham Young University and an MBA from the University of Washington.


Samuel Broder has joined the board of directors of Protein Design Labs, the Fremont, Calif.-based company said yesterday. He is the chief medical officer of Celera Genomics and Celera Diagnostics. Prior to that, he was senior vice president for research and development at Ivax, and before that, director of the National Cancer Institute. Broder has a medical degree and a bachelor's degree from the University of Michigan.


Google has appointed Shirley Tilghman, Princeton University's president and professor of molecular biology, to its board of directors. Tilghman was a member of the National Research Council committee that guided the US effort in the Human Genome Project and was a founding member of the National Advisory Council of the Human Genome Project Initiative for the National Institutes of Health. She was the founding director of Princeton's multi-disciplinary Lewis-Sigler Institute for Integrative Genomics and became the university's president in June 2001.

 

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.